Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study
Cancer Medicine · 2024
DOI: 10.1002/cam4.70315 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer Medicine, 2024. Verfasst von Wan-Ping Guo und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnos…. Hauptthemen laut MEDLINE: Nasopharyngeal Carcinoma, Palliative Care, Bone Neoplasms, Nasopharyngeal Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 52 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundamental Research Funds for the Central Universities, National Natural Science Foundation of China, Science and Technology Planning Project of Guangdong Province.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Objectives
Whether to perform local radiotherapy on metastatic bone for primary bone‐only oligometastatic nasopharyngeal carcinoma (NPC) patients remains unclear. Therefore, we analyzed the treatment methods and their survival and developed a prognostic model to predict outcomes and guide personalized treatment. Materials and Methods We studied 308 primary bone‐only oligometastatic NPC patients who were treated with either palliative chemotherapy (PCT) alone, PCT combined with locoregional radiotherapy (LRRT), or PCT, LRRT, and radiotherapy to metastatic bones (bRT). The primary endpoint was overall survival (OS). Cox regression was utilized to identify independent prognostic factors, leading to the construction of a nomogram model. Patients were stratified into two risk groups based on median prognostic scores, and treatment modalities were compared using log‐rank test while employing the inverse probability of treatment weighting (IPTW) to balance baseline characteristics and adjust for sample size differences between risk groups.
Results
The best OS was observed in the group treated with PCT, LRRT, and bRT (HR = 0.60, 95% CI: 0.45–0.81, p = 0.002). Multivariable analysis revealed that age, N stage, pre‐treatment levels of LDH, and EBV DNA were independent prognostic factors for OS. In total, 155 patients were in low‐risk group while 153 were in high‐risk group. Before and after IPTW, the high‐risk group benefited from the PCT, LRRT, and bRT regimen (adjusted HR = 0.53, 95% CI: 0.42–0.67, p < 0.001; unadjusted HR = 0.59, 95% CI: 0.42–0.83, p = 0.007), while the low‐risk group did not (adjusted HR = 0.79, 95% CI: 0.56–1.11, p = 0.345; unadjusted HR = 0.65, 95% CI: 0.37–1.14, p = 0.309).
Conclusion
Best outcomes of the whole cohort were seen with PCT + LRRT + bRT. Our study identified age, N stage, pre‐treatment LDH levels, and EBV DNA levels as independent prognostic factors for OS. The high‐risk group demonstrated a longer OS when treated with PCT + LRRT + bRT, whereas the low‐risk group did not benefit from the combinatorial treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Nasopharyngeal Carcinoma, State Key Laboratory of Oncology in South China, Guangdong Key Laboratory of Nasopharyngeal Carcinoma Diagnosis and Therapy, Guangdong Provincial Clinical Research Center for Canc…
ORCID-Profile: Dong-Hua Luo
Förderung
- Fundamental Research Funds for the Central Universities
- National Natural Science Foundation of China
- Science and Technology Planning Project of Guangdong Province
- Guangzhou Municipal Science and Technology Project
- Key Youth Teacher Cultivating Program of Sun Yat-sen University
- China National Postdoctoral Program for Innovative Talents
- Basic and Applied Basic Research Foundation of Guangdong Province
- Innovative Research Team of High-level Local University in Shanghai
Zitieren
APA
Guo, W. P., Jia, G. D., Xie, S. Y., Yu, X., Meng, X. H., Tang, L. Q., Li, X. Y., & Luo, D. H. (2024). Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study. Cancer Medicine. https://doi.org/10.1002/cam4.70315
Vancouver
Guo WP, Jia GD, Xie SY, Yu X, Meng XH, Tang LQ, et al. Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study. Cancer Medicine. 2024. doi:10.1002/cam4.70315
BibTeX
@article{Guo2024,
author = {Guo, Wan-Ping and Jia, Guo-Dong and Xie, Si-Yi and Yu, Xuan and Meng, Xiao-Han and Tang, Lin-Quan and Li, Xiao-Yun and Luo, Dong-Hua},
title = {Whether Primary Bone‐Only Oligometastatic Nasopharyngeal Carcinoma Patients Benefit From Radiotherapy to the Bones on the Basis of Palliative Chemotherapy Plus Locoregional Radiotherapy?—A Large‐Cohort Retrospective Study},
journal = {Cancer Medicine},
year = {2024},
doi = {10.1002/cam4.70315}
}
EUVIMED